Neogenomics Inc [NASDAQ: NEO] plunged by -$3.39 during the normal trading session on while it closed the day at $6.58.
Neogenomics Inc stock has also loss -32.51% of its value over the past 7 days. However, NEO stock has declined by -56.65% in the 3 months of the year. Over the past six months meanwhile, it has lost -49.58% and lost -60.07% year-on date.
The market cap for NEO stock reached $846.56 million, with 128.15 million shares outstanding and 127.12 million shares in the current float. Compared to the average trading volume of 1.48M shares, NEO reached a trading volume of 13073992 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Neogenomics Inc [NEO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NEO shares is $13.88 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NEO stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Benchmark Company have made an estimate for Neogenomics Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on January 13, 2025. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on December 10, 2024, representing the official price target for Neogenomics Inc stock. Previously, the target price had yet another raise to $26, while Craig Hallum analysts kept a Buy rating on NEO stock. On December 29, 2023, analysts decreased their price target for NEO shares from 25 to 21.
The Average True Range (ATR) for Neogenomics Inc is set at 0.85, with the Price to Sales ratio for NEO stock in the period of the last 12 months amounting to 1.28. The Price to Book ratio for the last quarter was 0.93, with the Price to Cash per share for the same quarter was set at 3.01.
NEO stock trade performance evaluation
Neogenomics Inc [NEO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -32.51. With this latest performance, NEO shares dropped by -31.60% in over the last four-week period, additionally sinking by -49.58% over the last 6 months – not to mention a drop of -52.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NEO stock in for the last two-week period is set at 26.72, with the RSI for the last a single of trading hit 20.42, and the three-weeks RSI is set at 30.71 for Neogenomics Inc [NEO]. The present Moving Average for the last 50 days of trading for this stock 9.84, while it was recorded at 9.36 for the last single week of trading, and 14.10 for the last 200 days.
Neogenomics Inc [NEO]: An insightful look at the core fundamentals
Neogenomics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.89 and a Current Ratio set at 1.98.
Earnings per share (EPS) analysis for Neogenomics Inc [NEO] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NEO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Neogenomics Inc go to 69.82%.
Neogenomics Inc [NEO]: Institutional Ownership
There are presently around $102.22%, or 103.32%% of NEO stock, in the hands of institutional investors. The top three institutional holders of NEO stocks are: BLACKROCK INC. with ownership of 19.67 million shares, which is approximately 15.5612%. VANGUARD GROUP INC, holding 14.12 million shares of the stock with an approximate value of $$195.87 million in NEO stocks shares; and VANGUARD GROUP INC, currently with $$121.66 million in NEO stock with ownership which is approximately 6.9391%.
